fda approval semaglutide mash Novo's Wegovy becomes first GLP-1 drug approved for FDA Approves Semaglutide to Treat

Due to the bodys natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.

Here's what you can do about it.

In an attempt to compensate for the loss, other pathways are upregulated, e.g., the increased use of ketones produced from fatty acids by astrocytes that are shuttled to neurons

Learn about safety, side effects, and how this combination affects weight loss under medical supervision.

They weigh up price, convenience, and perceived value, often making trade-offs that differ from traditional payer logic

Precision medicine approaches that leverage patient-specific markers offer a promising strategy to improve therapeutic outcomes